James T. Willerson - Concepedia

Author

James T. Willerson

The University of Texas Southwestern Medical Center

Also Known As

Bruno H. Stricker, Chambless, Lloyd, Couper, David, Cupples, L. Adrienne, H. McAllister, Holmes, Jr., David R, J T Willerson, J WILLERSON, J Willerson, J. T. WILLERSON

1.1K

Publications

73.3K

Citations

124

H-Index

320

Concepts

All Affiliations

The University of Texas Southwestern Medical Center The University of Texas Health Science Center at Houston University of Texas Health Science Center at Dallas St. Luke's Episcopal Hospital Baylor College of Medicine

About

James T. Willerson is an author at The University of Texas Southwestern Medical Center specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	36	56	4K
2	Engineering	22	24	1.3K
3	Education	2	2	494
4	Arts	1	1	13
5	Business	1	1	13

James T. Willerson

424

Publications

58.3K

Citations

114

H-Index

Page 1

	Year	Citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, New England Journal of Medicine	2008	6.5K
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Obstetrical & Gynecological Survey Vascular DiseaseElevated C-reactive ProteinUnstable AnginaHyperlipidemiaPharmacotherapy	2009	3.7K
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells Vincenzo Pasceri, James T. Willerson, Edward T.H. Yeh Circulation	2000	1.9K
Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction James E. Muller, Peter H. Stone, Zoltan G. Turi, New England Journal of Medicine	1985	1.9K
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure Eugene S. Chung, Milton Packer, Kim Hung Lo, Circulation	2003	1.6K
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure Emerson C. Perin, Hans Fernando Rocha Dohmann, Radovan Borojević, Circulation	2003	1.3K
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, The Lancet Jupiter TrialCardiovascular DiseaseHyperlipidemiaLdl CholesterolDyslipidemia	2009	1K
The VIVA Trial Timothy D. Henry, Brian H. Annex, George R. McKendall, Circulation	2003	1K
Appointment of New Associate Editor for <i>Circulation</i> James T. Willerson Circulation Practice ManagementPrimary CareCardiovascular DiseaseNew Associate EditorMedicine	1996	956
Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs Vincenzo Pasceri, J.Y. Chang, James T. Willerson, Circulation	2001	831

Page 1